Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Montalescot

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Heart (British Cardiac Society)|August 1, 1996
Homocysteine: the new player in the field of coronary riskG Montalescot
Presse Medicale (Paris, France : 1983)|July 10, 1999
[Low molecular weight heparin in unstable angina and myocardial infarction without Q wave]R Choussat, G Montalescot
Heart (British Cardiac Society)|March 20, 1998
Blocking platelets more: are we skating on thin ice?R Choussat, G Montalescot
Circulation|September 15, 1996
Images in cardiovascular medicine. Heart injury from firearmG Montalescot, D Thomas
Annales De Cardiologie Et D'Angeiologie|November 1, 1994
[Should all cases of aortic valve stenosis be surgically treated?]G Drobinski, G Montalescot
Heart (British Cardiac Society)|November 16, 2002
Transfer for primary angioplasty: who and how?M Dalby, G Montalescot
Presse Medicale (Paris, France : 1983)|March 7, 1992
[The cardiologist and anticoagulants: the heart has its reasons]G Montalescot, Y Grosgogeat
Revue Des Maladies Respiratoires|July 25, 2000
[New medical anticoagulants]R Choussat, G Montalescot
Journal of Thrombosis and Thrombolysis|June 22, 1999
Low molecular weight heparins in the cardiac catheterization laboratoryG Montalescot, M Cohen
European Heart Journal|May 1, 1990
Nitroglycerin-resistant coronary spasm treated with intracoronary linsidomine chlorhydrate (SIN-1)G Drobinski, G Montalescot
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Heart (British Cardiac Society)|August 1, 1996
Homocysteine: the new player in the field of coronary riskG Montalescot
Presse Medicale (Paris, France : 1983)|July 10, 1999
[Low molecular weight heparin in unstable angina and myocardial infarction without Q wave]R Choussat, G Montalescot
Heart (British Cardiac Society)|March 20, 1998
Blocking platelets more: are we skating on thin ice?R Choussat, G Montalescot
Circulation|September 15, 1996
Images in cardiovascular medicine. Heart injury from firearmG Montalescot, D Thomas
Annales De Cardiologie Et D'Angeiologie|November 1, 1994
[Should all cases of aortic valve stenosis be surgically treated?]G Drobinski, G Montalescot
Heart (British Cardiac Society)|November 16, 2002
Transfer for primary angioplasty: who and how?M Dalby, G Montalescot
Presse Medicale (Paris, France : 1983)|March 7, 1992
[The cardiologist and anticoagulants: the heart has its reasons]G Montalescot, Y Grosgogeat
Revue Des Maladies Respiratoires|July 25, 2000
[New medical anticoagulants]R Choussat, G Montalescot
Journal of Thrombosis and Thrombolysis|June 22, 1999
Low molecular weight heparins in the cardiac catheterization laboratoryG Montalescot, M Cohen
European Heart Journal|May 1, 1990
Nitroglycerin-resistant coronary spasm treated with intracoronary linsidomine chlorhydrate (SIN-1)G Drobinski, G Montalescot
Pageof 15